Delivery Order SPE2DB20D9329-SPE2DB22FD4LJ
- Not listed
- This is a $54,730.00 firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB indefinite delivery contract. The delivery order is for the supply of various pharmaceutical products, including 4561367145 YF-VAX 1 dose vials. The contract has an ultimate completion date of July 17, 2023. DMS Pharmaceutical Group is a key supplier of a wide range of medications and...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of various pharmaceutical products. The contract, valued at $13,523.76, is for the delivery of YF-VAX 1 dose vials and has an ultimate completion date of April 29, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, supporting the recurring medical supply needs of...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,126.98 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of YF-VAX 1-dose vials and has a completion date of June 26, 2024. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, which allows DLA to issue delivery orders for a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $1,127.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of YF-VAX 1 dose vials and has an ultimate completion date of September 18, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the recurring medical needs of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,113.42 firm fixed-price contract is for the delivery of YF-VAX 1 dose vials, with a performance period ending on May 23, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,113.42, is for the supply of YF-VAX 1 dose vials, a specialized pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of December 27, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of YF-VAX 1 dose vials, with a completion date of September 7, 2021. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,729.20 contract is for the delivery of YF-VAX 1 dose vials, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,226.84 contract is for the delivery of 4567805877 ! YF-VAX 1 DOSE VIALS, with a period of performance through April 23, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,567.10 firm fixed-price contract is for the delivery of YF-VAX 1 dose vials. The contract has a period of performance through May 28, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery orders for a...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB22FD4LJDelivery Order
This firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $45,560.00 contract is for the delivery of YF-VAX 1 dose vials, with a completion date of May 13, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This delivery order is not designated as a set-aside contract. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of medications and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA).
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.6k | 4/22/22 |